Nicole Labrosse - Net Worth and Insider Trading
Nicole Labrosse Net Worth
The estimated net worth of Nicole Labrosse is at least $750,316 dollars as of 2024-11-29. Nicole Labrosse is the SVP, CHIEF FINANCIAL OFFICER of Halozyme Therapeutics Inc and owns about 15,480 shares of Halozyme Therapeutics Inc (HALO) stock worth over $750,316. Details can be seen in Nicole Labrosse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicole Labrosse has not made any transactions after 2024-07-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nicole Labrosse
Nicole Labrosse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicole Labrosse owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of Nicole Labrosse’s form 4 insider trades.
Insider Ownership Summary of Nicole Labrosse
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2024-07-22 | SVP & Chief Financial Officer |
Nicole Labrosse Latest Holdings Summary
Nicole Labrosse currently owns a total of 1 stock. Nicole Labrosse owns 15,480 shares of Halozyme Therapeutics Inc (HALO) as of July 22, 2024, with a value of $750,316.
Latest Holdings of Nicole Labrosse
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2024-07-22 | 15,480 | 48.47 | 750,316 |
Holding Weightings of Nicole Labrosse
Nicole Labrosse Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicole Labrosse has made a total of 4 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 5,000 shares on July 22, 2024, which brought Nicole Labrosse around $269,650.
Insider Trading History of Nicole Labrosse
- 1
Nicole Labrosse Trading Performance
Nicole Labrosse Ownership Network
Nicole Labrosse Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Nicole Labrosse is the SVP & Chief Financial Officer of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & General Counsel Mark Howard Snyder .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Nicole Labrosse made 2 insider transaction in Halozyme Therapeutics Inc (HALO) with a net sale of 35,000. Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 120,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 120,000 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Nicole Labrosse Mailing Address
Above is the net worth, insider trading, and ownership report for Nicole Labrosse. You might contact Nicole Labrosse via mailing address: 11388 Sorrento Valley Road, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
